Global Pet Veterinary Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
The Pet Veterinary Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pet Veterinary Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Pet Veterinary Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pet Veterinary Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Market segment by Application can be divided into
Veterinary Hospitals
Veterinary Clinics
Drug Stores
The key market players for global Pet Veterinary Drug market are listed below:
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pet Veterinary Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Veterinary Drug, with price, sales, revenue and global market share of Pet Veterinary Drug in 2018 and 2019.
Chapter 3, the Pet Veterinary Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Veterinary Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pet Veterinary Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pet Veterinary Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Pet Veterinary Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pet Veterinary Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pet Veterinary Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.4 Global Pet Veterinary Drug Market Size & Forecast
1.4.1 Global Pet Veterinary Drug Sales in Value (2016-2026))
1.4.2 Global Pet Veterinary Drug Sales in Volume (2016-2026)
1.4.3 Global Pet Veterinary Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pet Veterinary Drug Production Capacity Analysis
1.5.1 Global Pet Veterinary Drug Total Production Capacity (2016-2026)
1.5.2 Global Pet Veterinary Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pet Veterinary Drug Market Drivers
1.6.2 Pet Veterinary Drug Market Restraints
1.6.3 Pet Veterinary Drug Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim International GmbH
2.1.1 Boehringer Ingelheim International GmbH Details
2.1.2 Boehringer Ingelheim International GmbH Major Business
2.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product and Services
2.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Zoetis Animal Healthcare
2.2.1 Zoetis Animal Healthcare Details
2.2.2 Zoetis Animal Healthcare Major Business
2.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Product and Services
2.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Pet Veterinary Drug Product and Services
2.3.4 Bayer AG Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Pet Veterinary Drug Product and Services
2.4.4 Merck Animal Health Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Elanco Animal Health Inc.
2.5.1 Elanco Animal Health Inc. Details
2.5.2 Elanco Animal Health Inc. Major Business
2.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Product and Services
2.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Virbac Group
2.6.1 Virbac Group Details
2.6.2 Virbac Group Major Business
2.6.3 Virbac Group Pet Veterinary Drug Product and Services
2.6.4 Virbac Group Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Pet Veterinary Drug Product and Services
2.7.4 Ceva Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Dechra Pharmaceuticals Plc
2.8.1 Dechra Pharmaceuticals Plc Details
2.8.2 Dechra Pharmaceuticals Plc Major Business
2.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product and Services
2.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Vetoquinol
2.9.1 Vetoquinol Details
2.9.2 Vetoquinol Major Business
2.9.3 Vetoquinol Pet Veterinary Drug Product and Services
2.9.4 Vetoquinol Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Orion Corporation
2.10.1 Orion Corporation Details
2.10.2 Orion Corporation Major Business
2.10.3 Orion Corporation Pet Veterinary Drug Product and Services
2.10.4 Orion Corporation Pet Veterinary Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pet Veterinary Drug Sales by Manufacturer
3.1 Global Pet Veterinary Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pet Veterinary Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pet Veterinary Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Pet Veterinary Drug Manufacturer Market Share
3.4.2 Top 6 Pet Veterinary Drug Manufacturer Market Share
3.5 Global Pet Veterinary Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pet Veterinary Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pet Veterinary Drug Market Size by Region
4.1.1 Global Pet Veterinary Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Pet Veterinary Drug Revenue by Region (2016-2026)
4.2 North America Pet Veterinary Drug Revenue (2016-2026)
4.3 Europe Pet Veterinary Drug Revenue (2016-2026)
4.4 Asia-Pacific Pet Veterinary Drug Revenue (2016-2026)
4.5 South America Pet Veterinary Drug Revenue (2016-2026)
4.6 Middle East and Africa Pet Veterinary Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pet Veterinary Drug Sales in Volume by Type (2016-2026)
5.2 Global Pet Veterinary Drug Revenue by Type (2016-2026)
5.3 Global Pet Veterinary Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pet Veterinary Drug Sales in Volume by Application (2016-2026)
6.2 Global Pet Veterinary Drug Revenue by Application (2016-2026)
6.3 Global Pet Veterinary Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pet Veterinary Drug Sales by Type (2016-2026)
7.2 North America Pet Veterinary Drug Sales by Application (2016-2026)
7.3 North America Pet Veterinary Drug Market Size by Country
7.3.1 North America Pet Veterinary Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Pet Veterinary Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pet Veterinary Drug Sales by Type (2016-2026)
8.2 Europe Pet Veterinary Drug Sales by Application (2016-2026)
8.3 Europe Pet Veterinary Drug Market Size by Country
8.3.1 Europe Pet Veterinary Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Pet Veterinary Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pet Veterinary Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Pet Veterinary Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Pet Veterinary Drug Market Size by Region
9.3.1 Asia-Pacific Pet Veterinary Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pet Veterinary Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pet Veterinary Drug Sales by Type (2016-2026)
10.2 South America Pet Veterinary Drug Sales by Application (2016-2026)
10.3 South America Pet Veterinary Drug Market Size by Country
10.3.1 South America Pet Veterinary Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Pet Veterinary Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pet Veterinary Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Pet Veterinary Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Pet Veterinary Drug Market Size by Country
11.3.1 Middle East & Africa Pet Veterinary Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pet Veterinary Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pet Veterinary Drug Typical Distributors
12.3 Pet Veterinary Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Pet Veterinary Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pet Veterinary Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim International GmbH Major Business
Table 5. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product and Services
Table 6. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Zoetis Animal Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Zoetis Animal Healthcare Major Business
Table 9. Zoetis Animal Healthcare Pet Veterinary Drug Product and Services
Table 10. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 12. Bayer AG Major Business
Table 13. Bayer AG Pet Veterinary Drug Product and Services
Table 14. Bayer AG Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 16. Merck Animal Health Major Business
Table 17. Merck Animal Health Pet Veterinary Drug Product and Services
Table 18. Merck Animal Health Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco Animal Health Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Animal Health Inc. Major Business
Table 21. Elanco Animal Health Inc. Pet Veterinary Drug Product and Services
Table 22. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Virbac Group Basic Information, Manufacturing Base and Competitors
Table 24. Virbac Group Major Business
Table 25. Virbac Group Pet Veterinary Drug Product and Services
Table 26. Virbac Group Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Ceva Basic Information, Manufacturing Base and Competitors
Table 28. Ceva Major Business
Table 29. Ceva Pet Veterinary Drug Product and Services
Table 30. Ceva Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Dechra Pharmaceuticals Plc Basic Information, Manufacturing Base and Competitors
Table 32. Dechra Pharmaceuticals Plc Major Business
Table 33. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product and Services
Table 34. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 36. Vetoquinol Major Business
Table 37. Vetoquinol Pet Veterinary Drug Product and Services
Table 38. Vetoquinol Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Orion Corporation Major Business
Table 41. Orion Corporation Pet Veterinary Drug Product and Services
Table 42. Orion Corporation Pet Veterinary Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Pet Veterinary Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Pet Veterinary Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Pet Veterinary Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Pet Veterinary Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Pet Veterinary Drug Production Site of Key Manufacturer
Table 48. Pet Veterinary Drug New Entrant and Capacity Expansion Plans
Table 49. Pet Veterinary Drug Mergers & Acquisitions in the Past Five Years
Table 50. Global Pet Veterinary Drug Sales by Region (2016-2021e) & (K Units)
Table 51. Global Pet Veterinary Drug Sales by Region (2021-2026) & (K Units)
Table 52. Global Pet Veterinary Drug Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Pet Veterinary Drug Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Pet Veterinary Drug Sales by Type (2016-2021e) & (K Units)
Table 55. Global Pet Veterinary Drug Sales by Type (2021-2026) & (K Units)
Table 56. Global Pet Veterinary Drug Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Pet Veterinary Drug Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Pet Veterinary Drug Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Pet Veterinary Drug Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Pet Veterinary Drug Sales by Application (2016-2021e) & (K Units)
Table 61. Global Pet Veterinary Drug Sales by Application (2021-2026) & (K Units)
Table 62. Global Pet Veterinary Drug Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Pet Veterinary Drug Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Pet Veterinary Drug Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Pet Veterinary Drug Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Pet Veterinary Drug Sales by Country (2016-2021e) & (K Units)
Table 67. North America Pet Veterinary Drug Sales by Country (2021-2026) & (K Units)
Table 68. North America Pet Veterinary Drug Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Pet Veterinary Drug Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Pet Veterinary Drug Sales by Type (2016-2021e) & (K Units)
Table 71. North America Pet Veterinary Drug Sales by Type (2021-2026) & (K Units)
Table 72. North America Pet Veterinary Drug Sales by Application (2016-2021e) & (K Units)
Table 73. North America Pet Veterinary Drug Sales by Application (2021-2026) & (K Units)
Table 74. Europe Pet Veterinary Drug Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Pet Veterinary Drug Sales by Country (2021-2026) & (K Units)
Table 76. Europe Pet Veterinary Drug Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Pet Veterinary Drug Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Pet Veterinary Drug Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Pet Veterinary Drug Sales by Type (2021-2026) & (K Units)
Table 80. Europe Pet Veterinary Drug Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Pet Veterinary Drug Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Pet Veterinary Drug Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Pet Veterinary Drug Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Pet Veterinary Drug Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Pet Veterinary Drug Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Pet Veterinary Drug Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Pet Veterinary Drug Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Pet Veterinary Drug Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Pet Veterinary Drug Sales by Application (2021-2026) & (K Units)
Table 90. South America Pet Veterinary Drug Sales by Country (2016-2021e) & (K Units)
Table 91. South America Pet Veterinary Drug Sales by Country (2021-2026) & (K Units)
Table 92. South America Pet Veterinary Drug Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Pet Veterinary Drug Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Pet Veterinary Drug Sales by Type (2016-2021e) & (K Units)
Table 95. South America Pet Veterinary Drug Sales by Type (2021-2026) & (K Units)
Table 96. South America Pet Veterinary Drug Sales by Application (2016-2021e) & (K Units)
Table 97. South America Pet Veterinary Drug Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Pet Veterinary Drug Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Pet Veterinary Drug Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Pet Veterinary Drug Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Pet Veterinary Drug Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Pet Veterinary Drug Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Pet Veterinary Drug Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Pet Veterinary Drug Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Pet Veterinary Drug Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Pet Veterinary Drug Typical Distributors
Table 109. Pet Veterinary Drug Typical Customers
List of Figures
Figure 1. Pet Veterinary Drug Picture
Figure 2. Global Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 3. Anti-Infectives
Figure 4. Anti-Inflammatory
Figure 5. Parasiticides
Figure 6. Analgesics
Figure 7. Sedatives
Figure 8. Others
Figure 9. Global Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 10. Veterinary Hospitals
Figure 11. Veterinary Clinics
Figure 12. Drug Stores
Figure 13. Global Pet Veterinary Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Pet Veterinary Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Pet Veterinary Drug Sales (2016-2026) & (K Units)
Figure 16. Global Pet Veterinary Drug Price by Type (2016-2026) & (USD/Unit)
Figure 17. Global Pet Veterinary Drug Production Capacity (2016-2026) & (K Units)
Figure 18. Global Pet Veterinary Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Pet Veterinary Drug Market Drivers
Figure 20. Pet Veterinary Drug Market Restraints
Figure 21. Pet Veterinary Drug Market Trends
Figure 22. Global Pet Veterinary Drug Sales Market Share by Manufacturer in 2020
Figure 23. Global Pet Veterinary Drug Revenue Market Share by Manufacturer in 2020
Figure 24. Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Pet Veterinary Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Pet Veterinary Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Pet Veterinary Drug Sales Market Share by Region (2016-2026)
Figure 28. Global Pet Veterinary Drug Revenue Market Share by Region (2016-2026)
Figure 29. North America Pet Veterinary Drug Revenue (2016-2026) & (USD Million)
Figure 30. Europe Pet Veterinary Drug Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Pet Veterinary Drug Revenue (2016-2026) & (USD Million)
Figure 32. South America Pet Veterinary Drug Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Pet Veterinary Drug Revenue (2016-2026) & (USD Million)
Figure 34. Global Pet Veterinary Drug Sales Market Share by Type (2016-2026)
Figure 35. Global Pet Veterinary Drug Revenue Market Share by Type (2016-2026)
Figure 36. Global Pet Veterinary Drug Price by Type (2016-2026) & (USD/Unit)
Figure 37. Global Pet Veterinary Drug Sales Market Share by Application (2016-2026)
Figure 38. Global Pet Veterinary Drug Revenue Market Share by Application (2016-2026)
Figure 39. Global Pet Veterinary Drug Price by Application (2016-2026) & (USD/Unit)
Figure 40. North America Pet Veterinary Drug Sales Market Share by Type (2016-2026)
Figure 41. North America Pet Veterinary Drug Sales Market Share by Application (2016-2026)
Figure 42. North America Pet Veterinary Drug Sales Market Share by Country (2016-2026)
Figure 43. North America Pet Veterinary Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Pet Veterinary Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Pet Veterinary Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Pet Veterinary Drug Sales Market Share by Country (2016-2026)
Figure 50. Europe Pet Veterinary Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Pet Veterinary Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Pet Veterinary Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Pet Veterinary Drug Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Pet Veterinary Drug Revenue Market Share by Region (2016-2026)
Figure 60. China Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Pet Veterinary Drug Sales Market Share by Type (2016-2026)
Figure 67. South America Pet Veterinary Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Pet Veterinary Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Pet Veterinary Drug Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Pet Veterinary Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Pet Veterinary Drug Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Pet Veterinary Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
